YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes - PubMed (original) (raw)
. 2012 Dec 6;31(49):5117-22.
doi: 10.1038/onc.2012.5. Epub 2012 Jan 30.
Affiliations
- PMID: 22286761
- DOI: 10.1038/onc.2012.5
YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes
T Mizuno et al. Oncogene. 2012.
Abstract
Malignant mesothelioma (MM) shows frequent inactivation of the neurofibromatosis type 2 (NF2) -tumor-suppressor gene. Recent studies have documented that the Hippo signaling pathway, a downstream cascade of Merlin (a product of NF2), has a key role in organ size control and carcinogenesis by regulating cell proliferation and apoptosis. We previously reported that MMs show overexpression of Yes-associated protein (YAP) transcriptional coactivator, the main downstream effector of the Hippo signaling pathway, which results from the inactivation of NF2, LATS2 and/or SAV1 genes (the latter two encoding core components of the mammalian Hippo pathway) or amplification of YAP itself. However, the detailed roles of YAP remain unclear, especially the target genes of YAP that enhance MM cell growth and survival. Here, we demonstrated that YAP-knockdown inhibited cell motility, invasion and anchorage-independent growth as well as cell proliferation of MM cells in vitro. We analyzed genes commonly regulated by YAP in three MM cell lines with constitutive YAP-activation, and found that the major subsets of YAP-upregulating genes encode cell cycle regulators. Among them, YAP directly induced the transcription of CCND1 and FOXM1, in cooperation with TEAD transcription factor. We also found that knockdown of CCND1 and FOXM1 suppressed MM cell proliferation, although the inhibitory effects were less evident than those of YAP knockdown. These results indicate that constitutive YAP activation in MM cells promotes cell cycle progression giving more aggressive phenotypes to MM cells.
Similar articles
- LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade.
Tanaka I, Osada H, Fujii M, Fukatsu A, Hida T, Horio Y, Kondo Y, Sato A, Hasegawa Y, Tsujimura T, Sekido Y. Tanaka I, et al. Oncogene. 2015 Jan 2;34(1):73-83. doi: 10.1038/onc.2013.528. Epub 2013 Dec 16. Oncogene. 2015. PMID: 24336325 - Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K, Osada H, Murakami-Tonami Y, Horio Y, Hida T, Sekido Y. Tanaka K, et al. Cancer Lett. 2017 Jan 28;385:215-224. doi: 10.1016/j.canlet.2016.10.020. Epub 2016 Oct 20. Cancer Lett. 2017. PMID: 27773750 - LATS2 is a tumor suppressor gene of malignant mesothelioma.
Murakami H, Mizuno T, Taniguchi T, Fujii M, Ishiguro F, Fukui T, Akatsuka S, Horio Y, Hida T, Kondo Y, Toyokuni S, Osada H, Sekido Y. Murakami H, et al. Cancer Res. 2011 Feb 1;71(3):873-83. doi: 10.1158/0008-5472.CAN-10-2164. Epub 2011 Jan 18. Cancer Res. 2011. PMID: 21245096 - Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.
Sekido Y. Sekido Y. Pathol Int. 2011 Jun;61(6):331-44. doi: 10.1111/j.1440-1827.2011.02666.x. Epub 2011 May 2. Pathol Int. 2011. PMID: 21615608 Review. - FOXM1 in sarcoma: role in cell cycle, pluripotency genes and stem cell pathways.
Kelleher FC, O'Sullivan H. Kelleher FC, et al. Oncotarget. 2016 Jul 5;7(27):42792-42804. doi: 10.18632/oncotarget.8669. Oncotarget. 2016. PMID: 27074562 Free PMC article. Review.
Cited by
- Role of cell rearrangement and related signaling pathways in the dynamic process of tip cell selection.
Guo Y, Zhang S, Wang D, Heng BC, Deng X. Guo Y, et al. Cell Commun Signal. 2024 Jan 9;22(1):24. doi: 10.1186/s12964-023-01364-1. Cell Commun Signal. 2024. PMID: 38195565 Free PMC article. Review. - Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells.
Sun Y, Hu L, Tao Z, Jarugumilli GK, Erb H, Singh A, Li Q, Cotton JL, Greninger P, Egan RK, Tony Ip Y, Benes CH, Che J, Mao J, Wu X. Sun Y, et al. Nat Commun. 2022 Nov 8;13(1):6744. doi: 10.1038/s41467-022-34559-0. Nat Commun. 2022. PMID: 36347861 Free PMC article. - Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma.
Pulito C, Korita E, Sacconi A, Valerio M, Casadei L, Lo Sardo F, Mori F, Ferraiuolo M, Grasso G, Maidecchi A, Lucci J, Sudol M, Muti P, Blandino G, Strano S. Pulito C, et al. J Exp Clin Cancer Res. 2019 Aug 9;38(1):349. doi: 10.1186/s13046-019-1352-3. J Exp Clin Cancer Res. 2019. PMID: 31399037 Free PMC article. - Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence.
Ou WB, Ni N, Zuo R, Zhuang W, Zhu M, Kyriazoglou A, Wu D, Eilers G, Demetri GD, Qiu H, Li B, Marino-Enriquez A, Fletcher JA. Ou WB, et al. Oncogene. 2019 Sep;38(39):6615-6629. doi: 10.1038/s41388-019-0894-3. Epub 2019 Aug 1. Oncogene. 2019. PMID: 31371779 - Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.
Vlacic G, Hoda MA, Klikovits T, Sinn K, Gschwandtner E, Mohorcic K, Schelch K, Pirker C, Peter-Vörösmarty B, Brankovic J, Dome B, Laszlo V, Cufer T, Rozman A, Klepetko W, Grasl-Kraupp B, Hegedus B, Berger W, Kern I, Grusch M. Vlacic G, et al. Cells. 2019 Sep 16;8(9):1091. doi: 10.3390/cells8091091. Cells. 2019. PMID: 31527449 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous